Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Innovation Pharmaceuticals IPIX
Posted On: 11/24/2015 8:20:39 PM
Post# of 72446
Posted By: F1ash
This from the actual la wsu it.

"Our scientific review has shown that Brilacidin is not effective even against EBSL
Enterobacteriaceae, unlike what Cellceutix claims. This means that Brilacidin is
not effective against any of the eight bacteria strains targeted in the Phase II"

How stupi d are these Rosen A-holes. If that was true how on gods green earth could the FDA approve moving to a Phase 3.

https://www.google.com/url?q=http://cellceuti...jpUcJCtfAw

The chart of the bacteria treated and the results are right there and were presented at Eccmid!













(0)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site